← Open Payments lookup

CARRIE WATSON: Open Payments

NPI 1700513504 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$452 in 17 payments from 9 companies in 2025. Trend: 2023 $319 · 2024 $259 · 2025 $452

Food & beverage: $452
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.5$118
AstraZeneca Pharmaceuticals LP2$105
Otsuka America Pharmaceutical, Inc.2$65
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$52
Lilly USA, LLC2$34
Paratek Pharmaceuticals, Inc.1$21
Inspire Medical Systems, Inc.1$20
Novo Nordisk Inc1$20
Esperion Therapeutics, Inc.1$18

Products named: GEMTESA, FARXIGA, REXULTI, CAPLYTA, MOUNJARO, NUZYRA, INSPIRE, Saxenda.

Industry payments across TX — which companies pay providers there.